Gómez-Ibáñez Asier, Garcés-Sánchez Mercedes, Hampel Kevin G, Cano-López Irene, Conde-Sardón Rebeca, Gutiérrez-Martín Antonio, Villanueva-Haba Vicente
Epilepsy Unit, Department of Neurology, Hospital Universitario y Politécnico La Fe, Avinguda de Fernando Abril Martorell, 106, 46026 Valencia, Spain.
Epilepsy Unit, Department of Neurology, Hospital Universitario y Politécnico La Fe, Avinguda de Fernando Abril Martorell, 106, 46026 Valencia, Spain.
J Neurol Sci. 2020 Jul 15;414:116872. doi: 10.1016/j.jns.2020.116872. Epub 2020 May 1.
Surgery is a well-demonstrated effective treatment for patients with refractory epilepsy. However, there are scarce data about the efficacy in older patients. Endpoint was to evaluate the outcome of epilepsy surgery in pharmacorresistant patients operated in middle-late adulthood.
We conducted a retrospective observational study including patients who underwent a epilepsy surgery at age ≥ 50. Presurgical clinical data, type of surgery, and postsurgical seizure outcome and neurological complications, including neuropsychological assessment were analyzed. Minimum post-surgical follow-up was 1 year.
We identified 38 patients (22 males, 17 females) out of 350 patients who underwent a resective surgery with curative intention in our Epilepsy Unit (12%). Median age at surgery was 56 years (50-69), with median epilepsy duration of 42 years (4-67). Neuroimaging showed focal epileptogenic lesions in 37 patients, mainly mesial temporal sclerosis (21). Presurgical neuropsychological evaluation was available in 38 patients: 35 had deficits, mostly in verbal or visual memory. Twenty-eight patients underwent standard temporal lobectomy with amygdalohippocampectomy, 7 lesionectomy and 4 lobectomy. Median follow-up was 4.46 years (1-9.75). A good outcome was achieved by 86.8% (28 Engel I; 5 Engel II); 5 patients were studied with SEEG, without any complications. None had postsurgical permanent neurological complications. From 22 patients with available post-surgical neuropsychological assessment, 16 scored lower than in pre-surgical one, mainly in memory domain.
Surgical treatment of long-term refractory epilepsy in patients ≥50 years can be effective and safe. Post-surgical memory decline is a frequent side effect, but with a low impact in daily life.
手术是治疗难治性癫痫患者的一种已被充分证明的有效方法。然而,关于老年患者手术疗效的数据却很少。研究终点是评估成年中后期接受手术治疗的药物难治性患者的癫痫手术结果。
我们进行了一项回顾性观察研究,纳入年龄≥50岁接受癫痫手术的患者。分析了术前临床数据、手术类型、术后癫痫发作结果和神经并发症,包括神经心理学评估。术后最短随访时间为1年。
在我们癫痫科350例接受根治性切除手术的患者中,我们确定了38例患者(22例男性,17例女性)(占12%)。手术时的中位年龄为56岁(50 - 69岁),癫痫中位病程为42年(4 - 67年)。神经影像学显示37例患者有局灶性致痫病变,主要为内侧颞叶硬化(21例)。38例患者有术前神经心理学评估结果:35例有缺陷,主要是言语或视觉记忆方面。28例患者接受了标准颞叶切除术加杏仁核海马切除术,7例接受了病灶切除术,4例接受了叶切除术。中位随访时间为4.46年(1 - 9.75年)。86.8%的患者预后良好(28例Engel I级;5例Engel II级);5例患者接受了立体定向脑电图检查,无任何并发症。无术后永久性神经并发症。在22例有术后神经心理学评估结果的患者中,16例术后评分低于术前,主要在记忆领域。
≥50岁患者长期难治性癫痫的手术治疗可能有效且安全。术后记忆下降是常见的副作用,但对日常生活影响较小。